FDA Drug information
Rubraca
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Rubraca RUCAPARIB CAMSYLATE 200 mg/1 Clovis Oncology, Inc.
- Rubraca RUCAPARIB CAMSYLATE 200 mg/1 pharmaand GmbH
- Rubraca RUCAPARIB CAMSYLATE 200 mg/1 ZR Pharma & GmbH
- Rubraca RUCAPARIB CAMSYLATE 250 mg/1 Clovis Oncology, Inc.
- Rubraca RUCAPARIB CAMSYLATE 250 mg/1 pharmaand GmbH
- Rubraca RUCAPARIB CAMSYLATE 250 mg/1 ZR Pharma & GmbH
- Rubraca RUCAPARIB CAMSYLATE 300 mg/1 Clovis Oncology, Inc.
- Rubraca RUCAPARIB CAMSYLATE 300 mg/1 pharmaand GmbH
- Rubraca RUCAPARIB CAMSYLATE 300 mg/1 ZR Pharma & GmbH
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.